Krystal Biotech (NASDAQ:KRYS) Delivers Strong Q2 Earnings and VYJUVEK Revenue Growth
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameKrystal Biotech, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









